
### [MONDO:0017758](http://purl.obolibrary.org/obo/MONDO_0017758)
**Label:** disorder of vitamin and non-protein cofactor absorption and transportB

**Subclasses:** [MONDO:0017578](http://purl.obolibrary.org/obo/MONDO_0017578) (disorder of thiamine metabolism and transport), [MONDO:0017313](http://purl.obolibrary.org/obo/MONDO_0017313) (disorder of folate metabolism and transport), [MONDO:0017214](http://purl.obolibrary.org/obo/MONDO_0017214) (vitamin B12-responsive methylmalonic acidemia), [MONDO:0018964](http://purl.obolibrary.org/obo/MONDO_0018964) (homocystinuria without methylmalonic aciduria), [MONDO:0017760](http://purl.obolibrary.org/obo/MONDO_0017760) (disorder of other vitamins and cofactors metabolism and transport), [MONDO:0010185](http://purl.obolibrary.org/obo/MONDO_0010185) (methylmalonic aciduria and homocystinuria type cblD), [MONDO:0009852](http://purl.obolibrary.org/obo/MONDO_0009852) (congenital intrinsic factor deficiency), [MONDO:0019220](http://purl.obolibrary.org/obo/MONDO_0019220) (disorder of cobalamin metabolism and transport), [MONDO:0009319](http://purl.obolibrary.org/obo/MONDO_0009319) (pantothenate kinase-associated neurodegeneration), [MONDO:0020480](http://purl.obolibrary.org/obo/MONDO_0020480) (sulfite oxidase deficiency due to molybdenum cofactor deficiency), [MONDO:0016826](http://purl.obolibrary.org/obo/MONDO_0016826) (methylmalonic acidemia with homocystinuria), [MONDO:0011841](http://purl.obolibrary.org/obo/MONDO_0011841) (biotin-responsive basal ganglia disease), [MONDO:0007272](http://purl.obolibrary.org/obo/MONDO_0007272) (hereditary hypercarotenemia and vitamin a deficiency), 

**Corr. equiv. classes:** [Orphanet:285657](http://www.orpha.net/ORDO/Orphanet_285657), [Orphanet:332](http://www.orpha.net/ORDO/Orphanet_332), [Orphanet:199285](http://www.orpha.net/ORDO/Orphanet_199285), [Orphanet:157850](http://www.orpha.net/ORDO/Orphanet_157850), [Orphanet:65284](http://www.orpha.net/ORDO/Orphanet_65284), [Orphanet:26](http://www.orpha.net/ORDO/Orphanet_26), [OMIM:115300](http://purl.obolibrary.org/obo/OMIM_115300), [Orphanet:28](http://www.orpha.net/ORDO/Orphanet_28), [OMIM:261000](http://purl.obolibrary.org/obo/OMIM_261000), [Orphanet:309833](http://www.orpha.net/ORDO/Orphanet_309833), [Orphanet:298644](http://www.orpha.net/ORDO/Orphanet_298644), [Orphanet:79171](http://www.orpha.net/ORDO/Orphanet_79171), [Orphanet:79283](http://www.orpha.net/ORDO/Orphanet_79283), [OMIM:234200](http://purl.obolibrary.org/obo/OMIM_234200), [OMIM:277410](http://purl.obolibrary.org/obo/OMIM_277410), [Orphanet:99732](http://www.orpha.net/ORDO/Orphanet_99732), [OMIM:607483](http://purl.obolibrary.org/obo/OMIM_607483), [Orphanet:622](http://www.orpha.net/ORDO/Orphanet_622), 

**Class expressions from DL-Learner:**

- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001263](http://purl.obolibrary.org/obo/HP_0001263) (Global developmental delay) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 51.16%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 49.24%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 49.24%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 46.16%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0001263](http://purl.obolibrary.org/obo/HP_0001263) (Global developmental delay) 41.84%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 41.01%
- [HP:0001254](http://purl.obolibrary.org/obo/HP_0001254) (Lethargy) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 38.29%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 32.13%
- Thing 32.12%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 32.12%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 30.19%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 27.60%
- [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 25.13%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 25.13%
- [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) 23.76%


